Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 10 days

Cancer Drug Resistance

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Articles

Most Recent | Most Viewed | Most Downloaded

ZEB2 upregulation modulates the polarization of TAMs toward the immunosuppressive state in EGFR-TKI-resistant NSCLC

Open Access Original Article DOI: 10.20517/cdr.2024.206 28 May 2025
Views: Downloads:
Download PDF

Advances in the application of patient-derived xenograft models in acute leukemia resistance

Open Access Review DOI: 10.20517/cdr.2025.18 27 May 2025
Views: Downloads:
Download PDF

FGFR1 overexpression promotes resistance to PI3K inhibitor alpelisib in luminal breast cancer cells through receptor tyrosine kinase signaling-mediated activation of the estrogen receptor

Open Access Original Article DOI: 10.20517/cdr.2024.181 27 May 2025
Views: Downloads:
Download PDF

Unveiling MAGEA3: a novel predictive biomarker for bevacizumab resistance in colorectal cancer

Open Access Original Article DOI: 10.20517/cdr.2025.35 27 Apr 2025
Views: Downloads:
Download PDF

Ivosidenib enhances cisplatin sensitivity in ovarian cancer by reducing cancer cell stemness

Open Access Original Article DOI: 10.20517/cdr.2025.51 23 Apr 2025
Views: Downloads:
Download PDF

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Open Access Review DOI: 10.20517/cdr.2023.16 19 Jun 2023
Views: Downloads:
Download PDF

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects

Open Access Review DOI: 10.20517/cdr.2022.136 28 Apr 2023
Views: Downloads:
Download PDF

Anti-BCMA novel therapies for multiple myeloma

Open Access Review DOI: 10.20517/cdr.2022.138 21 Mar 2023
Views: Downloads:
Download PDF
For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Articles Collection
In honor of National Cancer Survivors Month 2025, Cancer Drug Resistance (CDR) is offering a limited-time APC discount to support researchers in the vital field of cancer drug resistance.
We are thrilled to announce that Prof. Baiyong Shen, a globally recognized leader in pancreatic cancer research and Vice President of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, has officially joined Cancer Drug Resistance as an Associate Editor.
The webinar is scheduled for 7th May as an extension of the special issue.
We warmly welcome your participation and contributions.
This initiative not only recognizes the dedication of women in academia but also demonstrates our commitment to enhancing the participation of female scientists in high-impact research.
In celebration of International Women’s Day, this special collection highlights groundbreaking research from 2023 - 2024, led by female first or corresponding authors in our journal.

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN
Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/